Eagle Announces Success in Second Staph and Sales


TYLER, Texas, June 8, 2004 (PRIMEZONE) -- Eagle Worldwide Marketing, Inc. (OTC:EGWM) announced today that it has received confirming Staph Bacteria test results from a lab in Tennessee.

The following is an excerpt from a report dated May 17, 2004 from Leo Serrano, the Executive Director, Laboratory Services West Tennessee Healthcare:


 "Subject: Validation of Publication 'Study of a Proprietary Compound
  to Determine Effectiveness as an Antibacterial Agent'

  Dennis, I want to share with you the success we had validating the
  study done by Dr. John Paul Thompson on the antibacterial properties
  of 911 Relief. I returned this past weekend and reviewed all the
  test results, and they look stupendous.   As you know, we attempted
  to duplicate his study and findings as documented on the monograph
  you shared with us.

  We are very pleased to advise you that the study was very
  successful."

Dennis Holland, CEO of EGWM stated, "We had a great first quarter of this year, and it looks like we will have an even better second quarter. With the continued efforts of D.R. Johnson Sales and Marketing, and our presence at Grocery Trade Shows we have picked up more grocery suppliers and retail outlets. Our current grocery company customers continue to turn in orders and that is very encouraging.

With the continuing work of Dr. Stephen Goodwin, on behalf of 911 Relief, we are making deep in-rows into the medical community throughout the country."

About EAGLE

Based in Texas, Eagle distributes and markets safety products as well as homeopathic and antibacterial relief products, including 911 Relief, and various safety products. 911 Relief has been sold as a natural relief and antibacterial spray since 1991.

Forward-Looking Statement

The information in this release includes certain forward-looking statements that are based on assumptions that in the future may prove not to have been accurate. Those statements and Eagle are subject to a number of risks, including production variances from expectations, volatility of product prices, the capital expenditures required to fund its operations, environmental risks, competition, government regulation, and the ability of the company to implement its business strategy. These and other risks are described in the company's documents and reports that are available from the company. For additional information, view the company's website at www.eagleworldwidemarketing.com


            

Contact Data